Clinical Research Hub
Live Research Database

Eczema
Hub: Chicago, IL

Connecting patients in Chicago with breakthrough clinical trials, specialized care, and study-related compensation.

User
User
User
User
+4k
Join 4,200+ participants tracking trials in Illinois

Available Eczema Opportunities

9 Recruiting
NCT06504160(Verify)

Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

RECRUITING
Eczema
NCT07277660(Verify)

A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis

RECRUITING
Eczema
NCT07006792(Verify)

A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

RECRUITING
Eczema
NCT05042258(Verify)

Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis

RECRUITING
Eczema
NCT07265479(Verify)

A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

RECRUITING
Eczema
NCT06241118(Verify)

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

RECRUITING
Eczema
NCT06389136(Verify)

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

RECRUITING
Eczema
NCT06461897(Verify)

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

RECRUITING
Eczema
NCT06988605(Verify)

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

RECRUITING
Eczema

Patient Safeguards

IRB Oversight
Ethics Committee Approved
HIPAA Compliant
Full Data Privacy
NIH Standards
Global Quality Benchmarks

"Advancing Eczema research in Chicago through safe, transparent, and patient-first clinical trials."

Research Hubs in Chicago

Explore other local breakthroughs

Eczema Hubs in IL

Regional Network of Excellence

ClinicalTrials.govFDA REGISTEREDIRB OVERSIGHTHIPAA COMPLIANT